Amarin Corporation plc (NASDAQ:AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced select preliminary unaudited 2025 financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback